Acurable raises €11m in Series A funding round

London, 3rd October 2022

Company news

Acurable, an award-winning wearable medical devices company, today announced an €11m investment as a …

AcuPebble SA100 offers automated sleep apnoea diagnosis equivalent to cardiorespiratory polygraphy

London, 26th January 2022

Company news

AcuPebble SA100 is clinically equivalent to cardiorespiratory polygraphy for the automated diagnosis …

Acurable receives US FDA clearance for its home sleep apnoea testing device AcuPebble SA100

London, 29th November 2021

Company news

AcuPebble SA100, a small wearable device that enables automated, remote home testing to detect …